BioWorld

Nov. 8, 2004

View Archived Issues

Starting With 'Smaller, Perfect Pieces' To Make Larger Genes

Read More

Series C Round Brings In $11M To Antiviral Developer Chimerix

Read More

Other News To Note

Read More

Appointments And Advancements

Read More

VaxGen Wins $878M BioShield Contract For Anthrax Vaccine

Just a few days after the re-election of President Bush, the U.S. government awarded VaxGen Inc. an $877.5 million contract to supply anthrax vaccine for civilian defense. (BioWorld Today) Read More

Inhibitex Finishes IPO Job: Placement Brings In $50M

Read More